Lettmann Jason bought ALXO
September 16, 2025 · Form 4 insider transaction
Lettmann Jason bought 21,070 shares of ALX Oncology Holdings Inc. at $1.07 per share, a transaction worth $22.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,070
Price
$1.07
Total value
$22.5K
InsiderLettmann Jason
RoleOfficer, Director
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 16, 2025
Filing dateSeptember 18, 2025
Shares owned after233,958
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.